Trulicity denied by insurance? Appeal and win.
A denial of Trulicity is rarely the final word. It is usually the start of a process, and the most common reasons it gets stopped are step-therapy rules that ask you to try a preferred GLP-1 or other agent first, non-formulary or tier placement, and prior-authorization criteria the plan did not see fully documented. What flips these denials is a clean record of your type 2 diabetes diagnosis, the agents already tried or contraindicated, and a letter that maps your history directly onto the plan's own coverage criteria.
Reviewed by the Apellica Appeals Team · Updated June 2026
Carrier names and logos are trademarks of their respective owners. Apellica is independent and not affiliated with any insurance carrier or carrier's appeal program.
Trulicity (dulaglutide) is FDA-approved as an add-on to diet and exercise to improve blood sugar control in adults and in children 10 years and older with type 2 diabetes. It is also approved to reduce the risk of major adverse cardiovascular events, meaning cardiovascular death, heart attack, and stroke, in adults with type 2 diabetes who have established cardiovascular disease or multiple cardiovascular risk factors. It is not approved for type 1 diabetes and is not approved as a weight-loss drug.
Why Trulicity gets denied
- Step therapy not met: the plan requires a trial and failure of a preferred agent first, often metformin and sometimes a preferred GLP-1, before it will cover Trulicity.
- Non-formulary or higher-tier status: the plan prefers a different GLP-1 such as Ozempic or Mounjaro and places Trulicity off formulary or on a non-preferred tier.
- Prior-authorization criteria not documented: the submission lacks the type 2 diabetes diagnosis, recent A1C, or the record of prior medications needed to satisfy the policy.
- Suspected off-label or weight-loss use: claims that read as weight management, or that lack a type 2 diabetes diagnosis on file, are routinely refused because Trulicity is not approved for weight loss.
What a winning appeal includes
- Confirmed type 2 diabetes with the correct ICD-10 code (for example E11.9 or the relevant E11.- code) plus a recent A1C result that shows inadequate control.
- A documented history of prior therapy: metformin and any other agents tried, the dates, the response or failure, and any intolerance or contraindication that rules them out.
- Point-by-point mapping of the patient's chart to the plan's published PA or step-therapy criteria, so each required element is visibly satisfied.
- A letter of medical necessity from the prescriber that ties the diagnosis, the failed or contraindicated alternatives, and, where relevant, the cardiovascular indication to the request.
How we approach the appeal
First identify which denial you have, because the path differs. A step-therapy or PA denial is answered by submitting or re-submitting against the plan's published criteria with the diagnosis, A1C, and documented prior trials, and by requesting a step-therapy exception when a required drug was already tried, failed, or is contraindicated. A non-formulary placement is answered with a formulary or tier exception arguing medical necessity, quoting the plan's own exception language, and supporting it with a letter of medical necessity; if the plan still refuses, escalate to the formal internal appeal and then external review.
Trulicity appeal letter template
Copy this Trulicity appeal letter, fill in the brackets, and send it within your deadline. It is built on what overturns GLP-1 receptor agonist (once-weekly subcutaneous injection) denials.
[Date] [Your name] · Member ID [ID] · Rx claim # [#] [Insurer or PBM] - Appeals Department Re: Appeal of Trulicity denial I am appealing the denial of Trulicity (dulaglutide). I request that the denial be overturned and Trulicity approved. 1. The denial. [Insurer] denied Trulicity stating, verbatim: "[paste the exact denial reason from your letter]." 2. Medical necessity. Trulicity is medically necessary for my condition. First identify which denial you have, because the path differs. A step-therapy or PA denial is answered by submitting or re-submitting against the plan's published criteria with the diagnosis, A1C, and documented prior trials, and by requesting a step-therapy exception when a required drug was already tried, failed, or is contraindicated. A non-formulary placement is answered with a formulary or tier exception arguing medical necessity, quoting the plan's own exception language, and supporting it with a letter of medical necessity; if the plan still refuses, escalate to the formal internal appeal and then external review. 3. Step-therapy or formulary exception (if that was the reason): I have tried and failed [preferred drug(s)], with pharmacy records attached, or the preferred alternative is contraindicated because [reason]. I request a formulary or step-therapy exception. 4. My request. Approve Trulicity within the timeframe required by law. If the denial is upheld, please provide the specific criteria used, the reviewing clinician's credentials, and external-review instructions. Attached: prescriber letter of medical necessity, pharmacy and prior-trial records, and supporting clinical notes. Sincerely, [Your name]
Want it built and filed for you? Use the free generator, or have Apellica do it.
Internal appeals: 30 days pre-service, 60 days post-service, 72 hours urgent. File within 180 days of the denial.
$0 upfront. We assess fit first, then build and file the appeal for you.
- · The denial letter and your Explanation of Benefits (EOB)
- · Insurance ID, plan name, and the claim or prior-authorization number
- · Diagnosis with ICD-10 code and the prescriber's clinical notes
- · A record of treatments already tried and how they worked
Appealing a Trulicity denial by insurer
The path depends on who manages your benefit. The most common:
Coverage runs through the pharmacy benefit. Appeal the coverage determination and, when the drug is non-formulary, file a formulary or tier exception with a provider attestation that covered alternatives are unsuitable.
Publishes detailed prior-authorization criteria. A denial usually means a criterion was not documented. Appeal through a coverage review, with a formulary exception for excluded drugs.
Administers many UnitedHealthcare and employer plans. Appeals and exceptions follow the plan's published PA criteria; expedited review exists for urgent cases.
Internal appeal first, then independent external review. Pre-service decisions are generally made within 30 days, urgent within 72 hours.
Internal appeals and external review; pharmacy denials often route through OptumRx criteria.
Independent state plans, so criteria vary. Match the appeal to your specific BCBS plan, internal appeal first, then external review.
Frequently asked questions
My plan covers Ozempic or Mounjaro but denied Trulicity. Can I still get Trulicity?
Often yes, through a formulary or tier exception. The plan is steering you to its preferred GLP-1, but if you have tried a preferred agent and it did not work or caused side effects, or if there is a clinical reason your prescriber wants Trulicity specifically, that is the basis for an exception request supported by a letter of medical necessity.
I was denied because it looked like a weight-loss request. How do I fix that?
Trulicity is approved for type 2 diabetes and for cardiovascular risk reduction, not for weight loss, so a claim that reads as weight management will be refused. The fix is to make the type 2 diabetes diagnosis explicit with the ICD-10 code and a recent A1C, and to have the prescriber state the approved indication clearly in the request.
The plan says I have to try other drugs first. Do I really have to fail metformin again?
Not if you already have. Step therapy can be satisfied with documentation of past trials, so pull the records showing metformin or any other required agents were tried, with dates and outcomes. If a required drug is contraindicated or caused intolerance, request a step-therapy exception rather than repeating a treatment that already failed.
Does Trulicity's thyroid boxed warning affect my appeal?
It can help frame medical necessity but it is not the central issue for most denials. Trulicity is contraindicated in people with a personal or family history of medullary thyroid carcinoma or MEN 2, so confirming you do not have that history supports appropriateness. The appeal still turns on the diabetes diagnosis, prior therapy, and meeting the plan's criteria.
Trulicity denied? We fight it for you.
$0 upfront. Two-minute intake. We confirm fit and reply within one business day with the right path for your situation.
Start Your AppealThis page provides general information about appeal strategy. It is not legal or medical advice. Apellica is not a law firm. Outcomes depend on documentation, plan terms, and timing.